HERZUMA

Celltrion Inc🇨🇦 Health Canada

Approval Id: 1e5d495dc33c4b61
Drug Approval Canada Name: HERZUMA
Product Name: HERZUMA
Status: Marketed
Status Date: 2024-10-03
Original Market Date: 2019-12-11
Din: 02480794
Drug Class: Human
Dosage Form: Powder For Solution , Kit
Route Of Administration: Intravenous
Schedule: Schedule D , Prescription
Ahfs: 10:00.00
Atc Original: L01FD01 TRASTUZUMAB
Atc Name: l 01 fd 01
Aig Number: 0154252001
Company Name: Celltrion Inc
Company Address: 23 Academy-Ro, Yeonsu-Gu, Incheon, --, Korea, Republic Of, 22014
Company Detail Path: /organization/celltrion-inc

TRASTUZUMAB

440 MG / VIAL

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

1e5d495dc33c4b61

Type

Standard